Goldman Sachs Call 125 AP2 21.06..../ DE000GX9J2Z8 /
21/05/2024 10:43:55 | Var.+0.68 | Denaro22:00:39 | Lettera22:00:39 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
8.79EUR | +8.38% | - Quantità in denaro: - |
- Quantità in lettera: - |
APPLIED MATERIALS IN... | 125.00 - | 21/06/2024 | Call |
GlobeNewswire
07:30
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire
07:30
Aalberts N.V.: Aalberts sustained added value margin in challenging market environment
GlobeNewswire
07:25
Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, Belgium
GlobeNewswire
07:00
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire
07:00
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA app...
GlobeNewswire
04:45
INDEPENDENT BANK INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC ...
GlobeNewswire
04:45
GLOBE LIFE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS IN...
GlobeNewswire
04:44
OVERSEAS SHIPHOLDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, ...
GlobeNewswire
04:34
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS...
GlobeNewswire
04:32
LINCOLN NATIONAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMI...